Unit 5.3 - cell cycle control and tumors_SD_MM
Unit 5.3: Control of the Cell Cycle and Tumors
Learning Objectives
Describe how cells progress from one stage of the cell cycle to the next.
Describe the importance of cell cycle control and checkpoints.
Discuss the role of proto-oncoproteins and tumor suppressor proteins at checkpoints.
Predict the consequences of non-functional tumor suppressor proteins or hyper-active proto-oncoproteins.
Contrast cancer versus benign tumors and discuss the role of exposure to mutagens in the development of tumors.
The Cell-Cycle Control System: 3 Checkpoints
G1 Checkpoint:
Checks if environment is favorable to proceed to S phase.
Asks: Is DNA damaged?
G2 Checkpoint:
Checks if all DNA has been replicated and if there is any damage that needs repair.
M-phase Checkpoint:
Checks if all chromosomes are properly attached to the mitotic spindle.
Cell Cycle Phases:
G1, S, G2, and M phases.
Transition Through Cell Cycle Phases
Different cyclin proteins regulate transitions between cell cycle phases.
Cyclins and Cyclin-dependent Kinases (Cdks):
Cyclins rise in concentration towards the end of each phase.
Cyclins bind to and activate Cdks, promoting phase transitions.
G1 Checkpoint Details
The G1 Checkpoint:
It is the "master" checkpoint critical in preventing tumors.
Controlled by Proto-oncogenes (promoting division) and Tumor Suppressor proteins (halting division).
Process at G1 Checkpoint:
Promoting Cell Division:
Proto-oncoproteins ensure cells transition into S-phase.
Preventing Cell Division:
Tumor suppressor proteins can halt the cycle or induce apoptosis.
Malfunctions Leading to Tumor Formation
Two Main Malfunctions:
Proto-oncogenes overly expressed, leading to uncontrolled cell division.
Tumor suppressor genes not effectively expressed.
Consequence of malfunction:
Cells enter S phase without checks, leading to mutations and tumor formation.
Role of P53 Protein
P53 Protein Functions:
Check for DNA damage at G1 checkpoint.
Repair damaged DNA.
Arrest cell cycle at G1 until repair is complete.
Trigger apoptosis if damage is irreparable.
Cancerous Changes
Defective P53 associated with many cancers.
Cancer mechanisms:
Cells with DNA damage replicate uncontrollably.
Release of growth factors promoting further cell division.
Promote blood vessel growth to support tumor development.
Mutations and Their Triggers
Sources of Mutations:
Mistakes during DNA replication that may become permanent.
External damage from mutagens (UV radiation, toxins, etc.).
Example of a Mutagen:
UV light leading to thymine dimers.
Understanding Tumors
Tumors
Masses of cells dividing uncontrollably due to gene expression defects.
Types of Tumors:
Benign Tumors: Localized and do not spread.
Malignant Tumors: Can migrate (metastasize) and cause cancer.
Contrasting Benign and Malignant Tumors
Characteristics:
Benign: Well-differentiated, unspread.
Malignant: Poorly differentiated, capable of metastasis.
Mutations in control proteins lead to tumor distinction.
Cancer Treatment Approaches
Immunotherapy: Train immune system to attack cancer cells.
Angiogenesis Inhibitors: Cut off blood supply to tumors.
Targeted Drug Delivery: Chemotherapy limited to cancer cells, minimizing side effects.
Surgery: Remove tumors before metastasis.
Radiation Therapy: Destroy tumor cells and adjacent tissues.
Key Concepts Summary
The cell cycle requires regulation for proper cell division.
Checkpoints are crucial in regulating progress and preventing tumor formation.